Congenital, hereditary, and neonatal diseases and abnormalities

Case-based learning: pharmacy involvement in congenital heart disease

A comprehensive overview of the journey of a patient with congenital heart disease, from foetal to paediatric care, including perspectives from the parents and the medical team.…

Neonatal sepsis: prevention and management

The third article in a series on complications associated with prematurity and unwell neonates.…

Premature birth: managing associated complications

Part of a series of articles on the management of prematurity associated complications and the role of pharmacists.…

‘Serious gap’ in safe access to medicines for people with sensory impairment, report finds

In a report, the patient safety commissioner for England recommends a funding review to support additional resources to improve access to medicines for those with sensory impairments.…

Gastrointestinal complications associated with prematurity

An overview of gastrointestinal complications associated with premature birth and the role of parenteral nutrition in overcoming them.…

NICE recommends alternative corticosteroid for people with Duchenne muscular dystrophy

The guidance says that vamorolone reduces “adverse events” that are tied to other currently available corticosteroids, which include osteoporosis, weight gain and delayed puberty.…

Paediatric arrhythmias: pathophysiology, types and pharmaceutical management 

While many arrhythmias in children are harmless, it is vital to distinguish between the different types to ensure that potentially harmful ones are identified early and treatment plans are optimised for the patient.…

Declining use of sodium valproate linked to fall in birth defects among children, study results show

Children exposed to levetiracetam, oxcarbazepine and lamotrigine in the womb had the lowest prevalence of major congenital malformations.…

NHS to start routinely offering blindness drug to premature babies

Treatment with ranibizumab, which is administered using a precision injection system, would begin two or three days after diagnosis of retinopathy of prematurity.…

Government-funded research to screen genomes of 100,000 babies for rare diseases

The Newborn Genomes Programme, which will begin in 2023, will sequence the genomes of newborn babies to screen for rare conditions, to assess whether whole genome sequencing should be part of routine care.…